Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5 | 1 | 0 | 2 | 0 |
| Other current assets | 0 | 53 | 0 | 0 | 0 |
| TOTAL | $106 | $85 | $56 | $86 | $100 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $106 | $85 | $56 | $86 | $100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,067 | 4,924 | 4,608 | 4,307 | 4,085 |
| Accrued Expenses | 1,934 | 1,541 | 1,092 | 2,270 | 1,969 |
| TOTAL | $8,560 | $8,148 | $7,344 | $7,932 | $7,552 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $8,560 | $8,148 | $7,344 | $7,932 | $7,552 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 89,497 | 89,497 | 64,565 | 30,743 | 6,940 |
| Common Shares | 90 | 71 | 578 | 222 | 34 |
| Retained earnings | -171,661 | -170,810 | -169,751 | -168,272 | -167,456 |
| Other shareholders' equity | 22 | 22 | 22 | 22 | 22 |
| TOTAL | $-8,455 | $-8,063 | $-7,288 | $-7,847 | $-7,451 |
| Total Liabilities And Equity | $106 | $85 | $56 | $86 | $100 |